Rendered visual concept — not inventory photography. Label text in imagery is decorative.
Tissue Repair
TB-500
Currently unavailable
Thymosin β4 fragment (Ac-LKKTETQ, 17-23)
Strength
5 mg
Vial count
Unspecified
Strength of evidence
Mostly preclinical
Research summary
Synthetic fragment related to thymosin beta-4, studied mostly in preclinical models of cell migration.
Regulatory status
Not approved for human use in Canada.
No certificate of analysis or purity figure is shown because none has been verified for this demo. No dosing information is provided.
Information only. Purchases and payments are disabled.
Regulatory notice (Canada): Labelling a product “for research use only” does not make it legal to sell unapproved injectable peptides. In Canada, drugs for human use require Health Canada authorization. This site is a non-transactional design demo: nothing is for sale, and nothing here is medical advice or dosing guidance.